Emergent BioSolutions Inc.EBSNYSE
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank57
3Y CAGR-31.6%
5Y CAGR-19.9%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-31.6%/yr
vs +54.7%/yr prior
5Y CAGR
-19.9%/yr
Recent deceleration
Acceleration
-86.3pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $205.40M | +106.4% |
| 2024 | $99.50M | -10.9% |
| 2023 | $111.70M | -82.6% |
| 2022 | $642.60M | +11.5% |
| 2021 | $576.30M | -7.2% |
| 2020 | $621.30M | +269.8% |
| 2019 | $168.00M | +49.7% |
| 2018 | $112.20M | -37.1% |
| 2017 | $178.29M | -34.3% |
| 2016 | $271.51M | - |